Peer-influenced content. Sources you trust. No registration required. This is HCN.
MedPage Today
The film focuses on embalmers and funeral directors who claim to be coming forward to share their concerns over “unusual blood clots” found during prepared for burial, and Ryan Cole, MD, a promoter of false claims about the COVID vaccines and cancer. In the end, it is a combination of lies, theatrics, and scare tactics that rehash already-debunked claims.
All Specialties December 6th 2022
After earning a doctorate in nursing practice, this NP began to refer to herself as “Doctor Sarah Erny.” Now she must pay a civil fine and clean up her attribution.
All Specialties December 5th 2022
Pain Medicine News
Artri King and other products with a similar name were the subject of an FDA analysis that exposed hidden drug ingredients, including corticosteroids (diclofenac and dexamethasone). The FDA sent warning letters to Amazon, Walmart, and Latin Foods Market on October 28, 2022, for distributing various Artri and/or Ortiga unapproved and misbranded drug products. Some of these products may still be available on the market. These products have already been voluntarily recalled by Walmart and Latin Foods Market.
Family Medicine/General Practice November 16th 2022
In a three-page letter, Kathryn A. Coleman, director of the agency’s Medicare Drug and Health Plan Contract Administration Group, stated that CMS is immediately stepping up its examination of marketing materials, which are required to be submitted in accordance with its legal “File and Use” authority for Medicare Advantage and Part D drug plans, and “may exercise its authority to prohibit” their use. As of right now, Medicare Advantage marketing materials are allowed to go live five days after being submitted, as long as the company submitting them “certifies the material complies with all applicable standards.” Starting January 1, 2023, however, no television advertisements will be eligible for submission under its “File and Use” authority, meaning that the advertisements will not air until CMS approves them.
All Specialties November 9th 2022
Shortages of GLP-1 agonists are being driven by the number of Americans being overweight and the hype from Hollywood on the drug. But these aren’t the best choice for everyone seeking to lose weight.
Endocrinology, Diabetes, Metabolism November 9th 2022
This week’s edition of MedPage Today’s Investigative Roundup highlights some of the best investigative reporting on healthcare, including the lifechanging decision by Noble Health in Missouri to suspend all services and furlough 181 employees from Audrain Community Hospital and nearby Callaway Community Hospital.
All Specialties October 7th 2022